| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.799 | 0.004 | 0.799 | Anticonvulsant | 0.295 0.042 DBMET02789 | ||
| 0.643 | 0.008 | 0.643 | Nootropic | 0.24 0.117 DBMET02789 | ||
| 0.559 | 0.014 | 0.559 | Apoptosis antagonist | 0.402 0.038 DBMET02789 | ||
| 0.511 | 0.029 | 0.511 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.437 0.07 DBMET02789 | ||
| 0.498 | 0.029 | 0.509 | Calcium channel L-type activator | 0.509 0.024 DBMET02789 | DBMET02789 | |
| 0.41 | 0.017 | 0.419 | Interleukin agonist | 0.419 0.016 DBMET02789 | DBMET02789 | |
| 0.386 | 0.025 | 0.386 | Psychostimulant | 0.385 0.025 DBMET02789 | ||
| 0.407 | 0.081 | 0.407 | Analgesic | |||
| 0.374 | 0.051 | 0.374 | 5 Hydroxytryptamine release stimulant | 0.328 0.062 DBMET02789 | ||
| 0.356 | 0.036 | 0.388 | Tumour necrosis factor alpha release inhibitor | 0.388 0.029 DBMET02789 | DBMET02789 | |
| 0.355 | 0.043 | 0.4 | Interleukin 2 agonist | 0.4 0.027 DBMET02789 | DBMET02789 | |
| 0.3 | 0.016 | 0.3 | Hemostatic | 0.181 0.042 DBMET02789 | ||
| 0.308 | 0.029 | 0.372 | Tyrosine 3 hydroxylase inhibitor | 0.372 0.012 DBMET02789 | DBMET02789 | |
| 0.279 | 0.005 | 0.279 | Purinergic P2 antagonist | 0.085 0.029 DBMET02789 | ||
| 0.297 | 0.029 | 0.348 | Anticoagulant | 0.348 0.022 DBMET02789 | DBMET02789 | |
| 0.274 | 0.01 | 0.31 | Ferrochelatase inhibitor | 0.31 0.007 DBMET02789 | DBMET02789 | |
| 0.264 | 0.004 | 0.496 | Interleukin 12 antagonist | 0.496 0.003 DBMET02789 | DBMET02789 | |
| 0.265 | 0.02 | 0.474 | Interleukin 6 antagonist | 0.474 0.005 DBMET02789 | DBMET02789 | |
| 0.248 | 0.01 | 0.248 | Ca(v)2.2 blocker | |||
| 0.244 | 0.009 | 0.253 | Catalase inhibitor | 0.253 0.008 DBMET02789 | DBMET02789 | |
| 0.288 | 0.066 | 0.288 | Insulysin inhibitor | 0.282 0.071 DBMET02789 | ||
| 0.257 | 0.047 | 0.294 | Anesthetic general | 0.294 0.035 DBMET02789 | DBMET02789 | |
| 0.213 | 0.005 | 0.213 | Kallikrein inhibitor | |||
| 0.232 | 0.024 | 0.232 | Anesthetic local | 0.164 0.043 DBMET02789 | ||
| 0.301 | 0.096 | 0.466 | Vasodilator, peripheral | 0.466 0.036 DBMET02789 | DBMET02789 | |
| 0.192 | 0.004 | 0.192 | Purinergic P2X antagonist | 0.043 0.041 DBMET02789 | ||
| 0.289 | 0.103 | 0.33 | Calcium channel activator | 0.33 0.065 DBMET02789 | DBMET02789 | |
| 0.232 | 0.053 | 0.232 | Sigma receptor agonist | 0.166 0.075 DBMET02789 | ||
| 0.254 | 0.077 | 0.27 | 5 Hydroxytryptamine uptake stimulant | 0.27 0.064 DBMET02789 | DBMET02789 | |
| 0.189 | 0.013 | 0.192 | Sphingosine 1-phosphate receptor 2 agonist | 0.192 0.013 DBMET02789 | DBMET02789 | |
| 0.202 | 0.033 | 0.449 | Alpha-N-acetylglucosaminidase inhibitor | 0.449 0.007 DBMET02789 | DBMET02789 | |
| 0.179 | 0.011 | 0.179 | Cell adhesion molecule inhibitor | 0.102 0.033 DBMET02789 | ||
| 0.17 | 0.004 | 0.17 | Plasma kallikrein inhibitor | |||
| 0.216 | 0.053 | 0.216 | Growth hormone agonist | 0.178 0.068 DBMET02789 | ||
| 0.188 | 0.028 | 0.208 | Cell adhesion inhibitor | 0.208 0.023 DBMET02789 | DBMET02789 | |
| 0.161 | 0.004 | 0.161 | Somatostatin 5 agonist | |||
| 0.185 | 0.035 | 0.19 | Neurotrophic factor | 0.19 0.032 DBMET02789 | DBMET02789 | |
| 0.189 | 0.042 | 0.21 | Neurotensin receptor agonist | 0.21 0.03 DBMET02789 | DBMET02789 | |
| 0.278 | 0.131 | 0.305 | GABA C receptor rho-3 antagonist | 0.305 0.113 DBMET02789 | DBMET02789 | |
| 0.173 | 0.026 | 0.321 | GABA C receptor agonist | 0.321 0.008 DBMET02789 | DBMET02789 | |
| 0.191 | 0.045 | 0.191 | MAP kinase kinase 5 inhibitor | 0.164 0.102 DBMET02789 | ||
| 0.15 | 0.017 | 0.176 | Interleukin 1 beta converting enzyme inhibitor | 0.176 0.01 DBMET02789 | DBMET02789 | |
| 0.189 | 0.058 | 0.245 | Succinate dehydrogenase inhibitor | 0.245 0.024 DBMET02789 | DBMET02789 | |
| 0.181 | 0.051 | 0.214 | Acetylcholine M1 receptor antagonist | 0.214 0.037 DBMET02789 | DBMET02789 | |
| 0.151 | 0.022 | 0.158 | Prolactin inhibitor | 0.158 0.019 DBMET02789 | DBMET02789 | |
| 0.13 | 0.004 | 0.13 | Factor XIa inhibitor | 0.04 0.029 DBMET02789 | ||
| 0.165 | 0.039 | 0.165 | Nav1.3 sodium channel blocker | |||
| 0.22 | 0.095 | 0.22 | Calpain inhibitor | |||
| 0.127 | 0.004 | 0.127 | Neurokinin 2 agonist | 0.047 0.021 DBMET02789 | ||
| 0.124 | 0.004 | 0.124 | Factor XI inhibitor | 0.033 0.025 DBMET02789 | ||
| 0.145 | 0.027 | 0.145 | Acetylcholine agonist | |||
| 0.217 | 0.1 | 0.217 | Superoxide dismutase inhibitor | 0.217 0.101 DBMET02789 | ||
| 0.155 | 0.041 | 0.172 | Acetylcholine muscarinic antagonist | 0.172 0.033 DBMET02789 | DBMET02789 | |
| 0.122 | 0.009 | 0.122 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.033 DBMET02789 | ||
| 0.14 | 0.028 | 0.157 | Creatine kinase inhibitor | 0.157 0.021 DBMET02789 | DBMET02789 | |
| 0.111 | 0.003 | 0.148 | p53 inhibitor | 0.148 0.002 DBMET02789 | DBMET02789 | |
| 0.125 | 0.018 | 0.14 | Aminopeptidase I inhibitor | 0.14 0.014 DBMET02789 | DBMET02789 | |
| 0.157 | 0.053 | 0.157 | Nav1.2 sodium channel blocker | |||
| 0.14 | 0.036 | 0.174 | Caspase 3 inhibitor | 0.174 0.016 DBMET02789 | DBMET02789 | |
| 0.132 | 0.028 | 0.132 | Acetylcholine M3 receptor agonist | 0.111 0.039 DBMET02789 | ||
| 0.127 | 0.024 | 0.127 | Glutamate (mGluR7) agonist | 0.126 0.025 DBMET02789 | ||
| 0.133 | 0.03 | 0.133 | Acetylcholine release stimulant | 0.115 0.056 DBMET02789 | ||
| 0.208 | 0.105 | 0.208 | Neuropeptide Y2 antagonist | |||
| 0.107 | 0.005 | 0.107 | Corticotropin releasing factor 2 receptor antagonist | 0.081 0.016 DBMET02789 | ||
| 0.187 | 0.088 | 0.187 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.209 | 0.112 | 0.257 | Spasmolytic | 0.257 0.088 DBMET02789 | DBMET02789 | |
| 0.154 | 0.062 | 0.259 | Cell wall synthesis inhibitor | 0.259 0.014 DBMET02789 | DBMET02789 | |
| 0.097 | 0.005 | 0.097 | Kallikrein 7 inhibitor | 0.065 0.04 DBMET02789 | ||
| 0.104 | 0.012 | 0.104 | Antidiuretic hormone antagonist | |||
| 0.107 | 0.02 | 0.107 | Acetylcholine M2 receptor antagonist | 0.059 0.046 DBMET02789 | ||
| 0.134 | 0.049 | 0.134 | Calcium channel N-type blocker | |||
| 0.128 | 0.045 | 0.147 | GABA C receptor antagonist | 0.147 0.032 DBMET02789 | DBMET02789 | |
| 0.202 | 0.119 | 0.223 | Immunostimulant | 0.223 0.108 DBMET02789 | DBMET02789 | |
| 0.139 | 0.059 | 0.147 | Cholinergic antagonist | 0.147 0.054 DBMET02789 | DBMET02789 | |
| 0.142 | 0.063 | 0.142 | Nav1.6 sodium channel blocker | |||
| 0.095 | 0.017 | 0.102 | Acyl-CoA dehydrogenase inhibitor | 0.102 0.016 DBMET02789 | DBMET02789 | |
| 0.136 | 0.058 | 0.142 | Acetylcholine antagonist | 0.142 0.055 DBMET02789 | DBMET02789 | |
| 0.086 | 0.01 | 0.086 | Vasopressin 1 antagonist | |||
| 0.134 | 0.06 | 0.134 | Cathepsin H inhibitor | |||
| 0.085 | 0.015 | 0.085 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.14 | 0.073 | 0.164 | Ca2+-transporting ATPase inhibitor | 0.164 0.019 DBMET02789 | DBMET02789 | |
| 0.092 | 0.025 | 0.092 | Acetylcholine M5 receptor agonist | 0.08 0.034 DBMET02789 | ||
| 0.094 | 0.029 | 0.094 | CC chemokine 5 receptor agonist | 0.08 0.066 DBMET02789 | ||
| 0.072 | 0.008 | 0.072 | Melanocortin 3 agonist | |||
| 0.119 | 0.056 | 0.119 | 5 Hydroxytryptamine 3A agonist | |||
| 0.096 | 0.033 | 0.099 | Caspase 7 inhibitor | 0.099 0.029 DBMET02789 | DBMET02789 | |
| 0.117 | 0.055 | 0.161 | Aminopeptidase B inhibitor | 0.161 0.033 DBMET02789 | DBMET02789 | |
| 0.088 | 0.027 | 0.088 | Secretase beta inhibitor | |||
| 0.071 | 0.01 | 0.071 | Melanocortin agonist | |||
| 0.083 | 0.023 | 0.119 | Alcohol oxidase inhibitor | 0.119 0.014 DBMET02789 | DBMET02789 | |
| 0.065 | 0.005 | 0.099 | Kainate receptor agonist | 0.099 0.003 DBMET02789 | DBMET02789 | |
| 0.109 | 0.051 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET02789 | DBMET02789 | |
| 0.083 | 0.027 | 0.142 | Carbamoyl phosphate synthetase inhibitor | 0.142 0.012 DBMET02789 | DBMET02789 | |
| 0.067 | 0.011 | 0.067 | Oxytocin agonist | 0.055 0.021 DBMET02789 | ||
| 0.058 | 0.004 | 0.058 | Integrin alphaLbeta2 antagonist | 0.022 0.005 DBMET02789 | ||
| 0.072 | 0.019 | 0.072 | Opioid mu receptor agonist | |||
| 0.1 | 0.048 | 0.15 | Triose-phosphate isomerase inhibitor | 0.15 0.02 DBMET02789 | DBMET02789 | |
| 0.119 | 0.066 | 0.119 | Proteasome inhibitor | 0.106 0.079 DBMET02789 | ||
| 0.089 | 0.038 | 0.116 | Glutamate dehydrogenase inhibitor | 0.116 0.024 DBMET02789 | DBMET02789 | |
| 0.078 | 0.027 | 0.104 | Glutamate (mGluR6) antagonist | 0.104 0.009 DBMET02789 | DBMET02789 | |
| 0.061 | 0.011 | 0.061 | Vasopressin 1A antagonist | |||
| 0.061 | 0.013 | 0.061 | GHS receptor agonist | |||
| 0.091 | 0.044 | 0.166 | Glutamate receptor agonist | 0.166 0.015 DBMET02789 | DBMET02789 | |
| 0.107 | 0.059 | 0.107 | Protease inhibitor | 0.098 0.067 DBMET02789 | ||
| 0.091 | 0.045 | 0.091 | mTOR complex 2 inhibitor | 0.086 0.055 DBMET02789 | ||
| 0.058 | 0.012 | 0.058 | Melanocortin 1 agonist | |||
| 0.073 | 0.028 | 0.073 | Acetylcholine M5 receptor antagonist | |||
| 0.08 | 0.035 | 0.102 | Phospholipase D inhibitor | 0.102 0.013 DBMET02789 | DBMET02789 | |
| 0.054 | 0.009 | 0.054 | Peptide deformylase inhibitor | |||
| 0.197 | 0.153 | 0.262 | Gastrin inhibitor | 0.262 0.066 DBMET02789 | DBMET02789 | |
| 0.062 | 0.017 | 0.068 | CC chemokine receptor 2B antagonist | 0.068 0.013 DBMET02789 | DBMET02789 | |
| 0.049 | 0.005 | 0.049 | LFA antagonist | 0.046 0.006 DBMET02789 | ||
| 0.053 | 0.01 | 0.053 | Melanocortin 4 agonist | |||
| 0.062 | 0.019 | 0.062 | Melanocortin antagonist | |||
| 0.083 | 0.041 | 0.117 | Glutamate decarboxylase inhibitor | 0.117 0.022 DBMET02789 | DBMET02789 | |
| 0.06 | 0.019 | 0.06 | Melanocortin 4 antagonist | |||
| 0.208 | 0.168 | 0.305 | Antithrombotic | 0.305 0.084 DBMET02789 | DBMET02789 | |
| 0.051 | 0.011 | 0.051 | Delayed rectifier potassium channel blocker | |||
| 0.052 | 0.014 | 0.06 | GABA uptake inhibitor | 0.06 0.01 DBMET02789 | DBMET02789 | |
| 0.061 | 0.023 | 0.065 | Prolyl endopeptidase inhibitor | 0.065 0.019 DBMET02789 | DBMET02789 | |
| 0.059 | 0.021 | 0.059 | HCV NS3/NS4A protease inhibitor | 0.057 0.024 DBMET02789 | ||
| 0.07 | 0.032 | 0.092 | Biliverdin reductase inhibitor | 0.092 0.021 DBMET02789 | DBMET02789 | |
| 0.071 | 0.035 | 0.133 | NMDA receptor agonist | 0.133 0.01 DBMET02789 | DBMET02789 | |
| 0.043 | 0.008 | 0.043 | Adenosine uptake inhibitor | |||
| 0.132 | 0.097 | 0.153 | Adenylate cyclase stimulant | 0.153 0.057 DBMET02789 | DBMET02789 | |
| 0.06 | 0.026 | 0.06 | Dipeptidyl peptidase inhibitor | |||
| 0.06 | 0.026 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.016 DBMET02789 | DBMET02789 | |
| 0.063 | 0.03 | 0.079 | Ornithine carbamoyltransferase inhibitor | 0.079 0.022 DBMET02789 | DBMET02789 | |
| 0.066 | 0.034 | 0.066 | Histone deacetylase SIRT3 inhibitor | |||
| 0.047 | 0.016 | 0.047 | Purinergic P2X7 antagonist | |||
| 0.065 | 0.034 | 0.065 | Ribonucleotide reductase inhibitor | 0.052 0.041 DBMET02789 | ||
| 0.099 | 0.069 | 0.146 | Adenylate kinase inhibitor | 0.146 0.028 DBMET02789 | DBMET02789 | |
| 0.063 | 0.033 | 0.063 | Ribonucleoside-diphosphate reductase inhibitor | 0.051 0.04 DBMET02789 | ||
| 0.053 | 0.023 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.12 | 0.091 | 0.12 | Histone deacetylase SIRT1 inhibitor | |||
| 0.1 | 0.07 | 0.1 | Falcipain 3 inhibitor | |||
| 0.059 | 0.03 | 0.059 | Opioid agonist | |||
| 0.05 | 0.021 | 0.05 | Dipeptidyl peptidase IV inhibitor | |||
| 0.075 | 0.046 | 0.107 | Glycine receptor agonist | 0.107 0.017 DBMET02789 | DBMET02789 | |
| 0.087 | 0.059 | 0.087 | Histamine N-methyltransferase inhibitor | |||
| 0.033 | 0.005 | 0.033 | ICAM 1 antagonist | 0.027 0.009 DBMET02789 | ||
| 0.043 | 0.015 | 0.043 | Somatostatin agonist | |||
| 0.091 | 0.064 | 0.126 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.126 0.036 DBMET02789 | DBMET02789 | |
| 0.079 | 0.052 | 0.079 | Somatostatin 1 agonist | |||
| 0.045 | 0.019 | 0.083 | Kainate receptor 2 antagonist | 0.083 0.006 DBMET02789 | DBMET02789 | |
| 0.076 | 0.05 | 0.122 | Porphobilinogen synthase inhibitor | 0.122 0.028 DBMET02789 | DBMET02789 | |
| 0.045 | 0.021 | 0.072 | Membrane dipeptidase inhibitor | 0.072 0.007 DBMET02789 | DBMET02789 | |
| 0.044 | 0.021 | 0.069 | AMPA 4 receptor antagonist | 0.069 0.008 DBMET02789 | DBMET02789 | |
| 0.202 | 0.18 | 0.26 | Vasodilator, coronary | 0.26 0.125 DBMET02789 | DBMET02789 | |
| 0.03 | 0.008 | 0.03 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.059 | 0.038 | 0.118 | Argininosuccinate synthase inhibitor | 0.118 0.015 DBMET02789 | DBMET02789 | |
| 0.024 | 0.004 | 0.029 | Integrin beta2 antagonist | 0.029 0.004 DBMET02789 | DBMET02789 | |
| 0.077 | 0.058 | 0.09 | Interferon agonist | 0.09 0.038 DBMET02789 | DBMET02789 | |
| 0.083 | 0.065 | 0.083 | Opioid antagonist | |||
| 0.029 | 0.01 | 0.093 | Aminopeptidase P inhibitor | 0.093 0.002 DBMET02789 | DBMET02789 | |
| 0.101 | 0.083 | 0.101 | Calcium channel (voltage-sensitive) blocker | |||
| 0.038 | 0.019 | 0.038 | Somatostatin 5 antagonist | |||
| 0.047 | 0.029 | 0.059 | Mannosidase inhibitor | 0.059 0.018 DBMET02789 | DBMET02789 | |
| 0.168 | 0.151 | 0.187 | Peptidyltransferase inhibitor | 0.187 0.117 DBMET02789 | DBMET02789 | |
| 0.144 | 0.127 | 0.157 | Angiogenesis stimulant | 0.157 0.118 DBMET02789 | DBMET02789 | |
| 0.039 | 0.023 | 0.039 | Growth hormone secretagogue receptor antagonist | |||
| 0.124 | 0.109 | 0.124 | Thiol protease inhibitor | 0.124 0.108 DBMET02789 | ||
| 0.042 | 0.028 | 0.042 | Neurokinin 2 antagonist | |||
| 0.096 | 0.082 | 0.105 | Nav1.4 sodium channel blocker | 0.105 0.068 DBMET02789 | DBMET02789 | |
| 0.026 | 0.011 | 0.026 | Neurokinin 1 agonist | |||
| 0.088 | 0.075 | 0.112 | Lanosterol 14 alpha demethylase inhibitor | 0.112 0.039 DBMET02789 | DBMET02789 | |
| 0.069 | 0.055 | 0.076 | Cathepsin G inhibitor | 0.076 0.047 DBMET02789 | DBMET02789 | |
| 0.066 | 0.053 | 0.066 | Exportin-1 inhibitor | |||
| 0.034 | 0.021 | 0.034 | ADAM10 endopeptidase inhibitor | |||
| 0.069 | 0.057 | 0.069 | Metalloproteinase-9 inhibitor | |||
| 0.033 | 0.021 | 0.033 | GHS receptor antagonist | |||
| 0.061 | 0.049 | 0.061 | Prolactin release inhibitor | |||
| 0.134 | 0.122 | 0.156 | Tumour necrosis factor antagonist | 0.156 0.093 DBMET02789 | DBMET02789 | |
| 0.023 | 0.011 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET02789 | ||
| 0.022 | 0.01 | 0.043 | Factor IX inhibitor | 0.043 0.004 DBMET02789 | DBMET02789 | |
| 0.062 | 0.051 | 0.079 | Matrix metalloproteinase inhibitor | 0.079 0.038 DBMET02789 | DBMET02789 | |
| 0.021 | 0.011 | 0.027 | Caspase 8 inhibitor | 0.027 0.006 DBMET02789 | DBMET02789 | |
| 0.065 | 0.055 | 0.113 | MDM2 inhibitor | 0.113 0.005 DBMET02789 | DBMET02789 | |
| 0.134 | 0.124 | 0.353 | DNA methyltransferase I inhibitor | 0.353 0.014 DBMET02789 | DBMET02789 | |
| 0.06 | 0.051 | 0.06 | Neutrophil collagenase inhibitor | |||
| 0.051 | 0.042 | 0.051 | Acetylcholine muscarinic agonist | |||
| 0.038 | 0.029 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.072 | 0.063 | 0.082 | Metalloproteinase-2 inhibitor | 0.082 0.05 DBMET02789 | DBMET02789 | |
| 0.198 | 0.19 | 0.198 | Calpain 2 inhibitor | |||
| 0.027 | 0.019 | 0.027 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.038 | 0.031 | 0.04 | Toll-Like receptor 2 agonist | 0.04 0.03 DBMET02789 | DBMET02789 | |
| 0.087 | 0.08 | 0.14 | Electrolyte absorption antagonist | 0.14 0.023 DBMET02789 | DBMET02789 | |
| 0.074 | 0.067 | 0.093 | Glycine receptor antagonist | 0.093 0.039 DBMET02789 | DBMET02789 | |
| 0.055 | 0.048 | 0.055 | Bombesin 1 receptor agonist | |||
| 0.032 | 0.026 | 0.032 | CDK6/cyclin D3 inhibitor | 0.031 0.03 DBMET02789 | ||
| 0.138 | 0.132 | 0.16 | Phospholipase C inhibitor | 0.16 0.087 DBMET02789 | DBMET02789 | |
| 0.029 | 0.023 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.059 | 0.054 | 0.059 | Opioid mu receptor antagonist | |||
| 0.037 | 0.032 | 0.075 | Integrin antagonist | 0.075 0.021 DBMET02789 | DBMET02789 | |
| 0.033 | 0.029 | 0.033 | Opioid delta receptor agonist | |||
| 0.024 | 0.019 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.034 | 0.03 | 0.034 | Melanocortin 1 antagonist | |||
| 0.049 | 0.045 | 0.049 | Human rhinovirus A protease inhibitor | |||
| 0.03 | 0.027 | 0.031 | Calcitonin receptor agonist | 0.031 0.026 DBMET02789 | DBMET02789 | |
| 0.027 | 0.024 | 0.027 | Vasopressin 1A agonist | |||
| 0.031 | 0.028 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 DBMET02789 | DBMET02789 | |
| 0.032 | 0.029 | 0.054 | Arginase inhibitor | 0.054 0.013 DBMET02789 | DBMET02789 | |
| 0.037 | 0.035 | 0.037 | Acetylcholine M1 receptor agonist | |||
| 0.043 | 0.042 | 0.045 | Cholesterol esterase inhibitor | 0.045 0.037 DBMET02789 | DBMET02789 | |
| 0.052 | 0.05 | 0.052 | Immunoglobulin Fc receptor antagonist | |||
| 0.05 | 0.048 | 0.05 | Sphingosine kinase 2 inhibitor | |||
| 0.033 | 0.032 | 0.033 | Factor X inhibitor | |||
| 0.049 | 0.048 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.121 | 0.122 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | 0.145 0.07 DBMET02789 | DBMET02789 | |
| 0.068 | 0.07 | 0.076 | Vanilloid 4 agonist | 0.076 0.049 DBMET02789 | DBMET02789 | |
| 0.058 | 0.059 | 0.065 | Interferon inducer | 0.065 0.043 DBMET02789 | DBMET02789 | |
| 0.039 | 0.041 | 0.046 | Adenosine deaminase inhibitor | 0.046 0.035 DBMET02789 | DBMET02789 | |
| 0.15 | 0.152 | 0.224 | Cyclic AMP phosphodiesterase inhibitor | 0.224 0.078 DBMET02789 | DBMET02789 | |
| 0.132 | 0.135 | 0.341 | DNA methylase inhibitor | 0.341 0.018 DBMET02789 | DBMET02789 | |
| 0.015 | 0.02 | 0.035 | Kainate receptor 1 antagonist | 0.035 0.008 DBMET02789 | DBMET02789 | |
| 0.043 | 0.048 | 0.054 | Bombesin 2 receptor antagonist | 0.054 0.028 DBMET02789 | DBMET02789 | |
| 0.022 | 0.028 | 0.042 | AMPA 3 receptor antagonist | 0.042 0.013 DBMET02789 | DBMET02789 | |
| 0.166 | 0.174 | 0.213 | DNA synthesis inhibitor | 0.213 0.103 DBMET02789 | DBMET02789 | |
| 0.108 | 0.122 | 0.117 | Vanilloid 1 agonist | 0.117 0.096 DBMET02789 | DBMET02789 | |
| 0.016 | 0.031 | 0.027 | Kainate receptor 4 antagonist | 0.027 0.015 DBMET02789 | DBMET02789 | |
| 0.019 | 0.034 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.015 DBMET02789 | DBMET02789 | |
| 0.007 | 0.023 | 0.023 | Angiotensin AT1B receptor antagonist | 0.023 0.005 DBMET02789 | DBMET02789 | |
| 0.108 | 0.125 | 0.384 | Thrombolytic | 0.384 0.013 DBMET02789 | DBMET02789 | |
| 0.013 | 0.03 | 0.046 | 5-Alpha-reductase 2 inhibitor | 0.046 0.007 DBMET02789 | DBMET02789 | |
| 0.026 | 0.044 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.018 DBMET02789 | DBMET02789 | |
| 0.045 | 0.064 | 0.081 | Angiotensin-converting enzyme inhibitor | 0.081 0.013 DBMET02789 | DBMET02789 | |
| 0.009 | 0.028 | 0.044 | 5-Alpha-reductase 1 inhibitor | 0.044 0.007 DBMET02789 | DBMET02789 | |
| 0.015 | 0.035 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.015 DBMET02789 | DBMET02789 | |
| 0.095 | 0.115 | 0.122 | Toll-Like receptor 2 antagonist | 0.122 0.076 DBMET02789 | DBMET02789 | |
| 0.025 | 0.049 | 0.049 | Kainate receptor antagonist | 0.049 0.022 DBMET02789 | DBMET02789 | |
| 0.06 | 0.084 | 0.08 | GABA aminotransferase inhibitor | 0.08 0.046 DBMET02789 | DBMET02789 | |
| 0.014 | 0.038 | 0.026 | AMPA 1 receptor antagonist | 0.026 0.023 DBMET02789 | DBMET02789 | |
| 0.231 | 0.256 | 0.31 | 5 Hydroxytryptamine release inhibitor | 0.31 0.154 DBMET02789 | DBMET02789 | |
| 0.082 | 0.109 | 0.218 | Interleukin 1b antagonist | 0.218 0.016 DBMET02789 | DBMET02789 | |
| 0.018 | 0.045 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET02789 | DBMET02789 | |
| 0.01 | 0.037 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.014 DBMET02789 | DBMET02789 | |
| 0.134 | 0.164 | 0.406 | Platelet antagonist | 0.406 0.026 DBMET02789 | DBMET02789 | |
| 0.045 | 0.077 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 DBMET02789 | DBMET02789 | |
| 0.016 | 0.05 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.019 DBMET02789 | DBMET02789 | |
| 0.105 | 0.14 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.085 DBMET02789 | DBMET02789 | |
| 0.028 | 0.064 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.026 DBMET02789 | DBMET02789 | |
| 0.074 | 0.112 | 0.102 | Anabolic | 0.102 0.06 DBMET02789 | DBMET02789 | |
| 0.117 | 0.157 | 0.172 | Interleukin antagonist | 0.172 0.102 DBMET02789 | DBMET02789 | |
| 0.033 | 0.075 | 0.047 | Glutamate (mGluR group III) antagonist | 0.047 0.025 DBMET02789 | DBMET02789 | |
| 0.027 | 0.069 | 0.065 | Antimetabolite | 0.065 0.023 DBMET02789 | DBMET02789 | |
| 0.018 | 0.06 | 0.06 | 5-Alpha-reductase inhibitor | 0.06 0.016 DBMET02789 | DBMET02789 | |
| 0.022 | 0.065 | 0.052 | Angiotensin II receptor antagonist | 0.052 0.006 DBMET02789 | DBMET02789 | |
| 0.048 | 0.091 | 0.058 | Ryanodine receptor antagonist | 0.058 0.044 DBMET02789 | DBMET02789 | |
| 0.025 | 0.07 | 0.059 | Angiotensin AT1 receptor antagonist | 0.059 0.007 DBMET02789 | DBMET02789 | |
| 0.049 | 0.094 | 0.094 | CXC chemokine receptor antagonist | 0.094 0.028 DBMET02789 | DBMET02789 | |
| 0.033 | 0.084 | 0.062 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DBMET02789 | DBMET02789 | |
| 0.031 | 0.082 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET02789 | DBMET02789 | |
| 0.045 | 0.097 | 0.074 | Na+ K+ transporting ATPase inhibitor | 0.074 0.056 DBMET02789 | DBMET02789 | |
| 0.066 | 0.117 | 0.105 | NADH dehydrogenase inhibitor | 0.105 0.038 DBMET02789 | DBMET02789 | |
| 0.004 | 0.056 | 0.011 | Thromboxane agonist | 0.011 0.007 DBMET02789 | DBMET02789 | |
| 0.022 | 0.075 | 0.036 | Glutamate (mGluR3) antagonist | 0.036 0.026 DBMET02789 | DBMET02789 | |
| 0.092 | 0.146 | 0.212 | Interleukin 1 antagonist | 0.212 0.028 DBMET02789 | DBMET02789 | |
| 0.018 | 0.073 | 0.114 | GP IIb/IIIa receptor antagonist | 0.114 0.015 DBMET02789 | DBMET02789 | |
| 0.034 | 0.089 | 0.066 | Factor IXa inhibitor | 0.066 0.023 DBMET02789 | DBMET02789 | |
| 0.226 | 0.283 | 0.332 | Caspase 9 stimulant | 0.332 0.161 DBMET02789 | DBMET02789 | |
| 0.119 | 0.176 | 0.313 | Aldehyde oxidase inhibitor | 0.313 0.063 DBMET02789 | DBMET02789 | |
| 0.06 | 0.122 | 0.081 | Antihistaminic | 0.081 0.077 DBMET02789 | DBMET02789 | |
| 0.064 | 0.126 | 0.096 | UDP-glucose 4-epimerase inhibitor | 0.096 0.066 DBMET02789 | DBMET02789 | |
| 0.088 | 0.15 | 0.13 | Peroxidase inhibitor | 0.13 0.091 DBMET02789 | DBMET02789 | |
| 0.047 | 0.11 | 0.065 | Glutamate (mGluR7) antagonist | 0.065 0.053 DBMET02789 | DBMET02789 | |
| 0.023 | 0.088 | 0.056 | MAP3K5 inhibitor | 0.056 0.008 DBMET02789 | DBMET02789 | |
| 0.059 | 0.126 | 0.233 | Chemokine receptor antagonist | 0.233 0.013 DBMET02789 | DBMET02789 | |
| 0.075 | 0.145 | 0.104 | DOPA decarboxylase inhibitor | 0.104 0.069 DBMET02789 | DBMET02789 | |
| 0.018 | 0.089 | 0.05 | Purinergic P2Y antagonist | 0.05 0.026 DBMET02789 | DBMET02789 | |
| 0.003 | 0.077 | 0.024 | Prostaglandin EP4 agonist | 0.024 0.008 DBMET02789 | DBMET02789 | |
| 0.01 | 0.085 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.009 DBMET02789 | DBMET02789 | |
| 0.02 | 0.097 | 0.039 | Integrin alpha5beta1 antagonist | 0.039 0.03 DBMET02789 | DBMET02789 | |
| 0.024 | 0.101 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.023 DBMET02789 | DBMET02789 | |
| 0.022 | 0.1 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.029 DBMET02789 | DBMET02789 | |
| 0.036 | 0.114 | 0.068 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.048 DBMET02789 | DBMET02789 | |
| 0.03 | 0.11 | 0.059 | Aconitate hydratase inhibitor | 0.059 0.027 DBMET02789 | DBMET02789 | |
| 0.111 | 0.193 | 0.208 | Lipocortins synthesis antagonist | 0.208 0.052 DBMET02789 | DBMET02789 | |
| 0.088 | 0.17 | 0.221 | Diuretic | 0.221 0.037 DBMET02789 | DBMET02789 | |
| 0.064 | 0.146 | 0.081 | Estrogen-related receptor beta agonist | 0.081 0.064 DBMET02789 | DBMET02789 | |
| 0.065 | 0.15 | 0.098 | Nav1.1 sodium channel blocker | 0.098 0.068 DBMET02789 | DBMET02789 | |
| 0.115 | 0.201 | 0.155 | Neurotrophic factor enhancer | 0.155 0.131 DBMET02789 | DBMET02789 | |
| 0.069 | 0.16 | 0.121 | Microtubule formation inhibitor | 0.121 0.059 DBMET02789 | DBMET02789 | |
| 0.024 | 0.12 | 0.045 | Lysophosphatidic acid 3 receptor antagonist | 0.045 0.044 DBMET02789 | DBMET02789 | |
| 0.043 | 0.139 | 0.076 | Ornithine decarboxylase inhibitor | 0.076 0.072 DBMET02789 | DBMET02789 | |
| 0.022 | 0.119 | 0.141 | CC chemokine 5 receptor antagonist | 0.141 0.005 DBMET02789 | DBMET02789 | |
| 0.01 | 0.12 | 0.039 | Prostaglandin D2 agonist | 0.039 0.013 DBMET02789 | DBMET02789 | |
| 0.01 | 0.12 | 0.051 | Complement C3a chemotactic receptor antagonist | 0.051 0.026 DBMET02789 | DBMET02789 | |
| 0.033 | 0.149 | 0.103 | Histamine H1 receptor antagonist | 0.103 0.04 DBMET02789 | DBMET02789 | |
| 0.004 | 0.12 | 0.019 | Neutral endopeptidase inhibitor | 0.019 0.017 DBMET02789 | DBMET02789 | |
| 0.031 | 0.151 | 0.064 | Sphingosine 1-phosphate receptor 5 agonist | 0.064 0.021 DBMET02789 | DBMET02789 | |
| 0.017 | 0.146 | 0.06 | Thymidylate synthase inhibitor | 0.06 0.017 DBMET02789 | DBMET02789 | |
| 0.178 | 0.309 | 0.451 | Cyclophilin D inhibitor | 0.451 0.066 DBMET02789 | DBMET02789 | |
| 0.08 | 0.21 | 0.17 | Arachidonic acid antagonist | 0.17 0.065 DBMET02789 | DBMET02789 | |
| 0.037 | 0.168 | 0.122 | NMDA receptor antagonist | 0.122 0.035 DBMET02789 | DBMET02789 | |
| 0.058 | 0.19 | 0.093 | Mucolytic | 0.093 0.087 DBMET02789 | DBMET02789 | |
| 0.044 | 0.18 | 0.103 | Viral attachment inhibitor | 0.103 0.022 DBMET02789 | DBMET02789 | |
| 0.008 | 0.15 | 0.032 | Retinoid X receptor agonist | 0.032 0.028 DBMET02789 | DBMET02789 | |
| 0.031 | 0.173 | 0.159 | CC chemokine receptor antagonist | 0.159 0.016 DBMET02789 | DBMET02789 | |
| 0.105 | 0.252 | 0.237 | Cardiotonic | 0.237 0.091 DBMET02789 | DBMET02789 | |
| 0.055 | 0.208 | 0.123 | Bone formation stimulant | 0.123 0.083 DBMET02789 | DBMET02789 | |
| 0.142 | 0.305 | 0.266 | Histamine release inhibitor | 0.266 0.144 DBMET02789 | DBMET02789 | |
| 0.007 | 0.171 | 0.028 | Prostaglandin agonist | 0.028 0.026 DBMET02789 | DBMET02789 | |
| 0.046 | 0.241 | 0.159 | Amylase inhibitor | 0.159 0.06 DBMET02789 | DBMET02789 | |
| 0.043 | 0.242 | 0.088 | Bile acid receptor antagonist | 0.088 0.079 DBMET02789 | DBMET02789 | |
| 0.127 | 0.34 | 0.266 | Antibacterial | 0.266 0.162 DBMET02789 | DBMET02789 | |
| 0.105 | 0.321 | 0.274 | Cholesterol antagonist | 0.274 0.109 DBMET02789 | DBMET02789 | |
| 0.021 | 0.253 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.029 DBMET02789 | DBMET02789 | |
| 0.031 | 0.284 | 0.102 | Cholesterol synthesis inhibitor | 0.102 0.085 DBMET02789 | DBMET02789 | |
| 0.031 | 0.328 | 0.126 | Chelator | 0.126 0.048 DBMET02789 | DBMET02789 | |
| 0.084 | 0.407 | 0.284 | Antiobesity | 0.284 0.128 DBMET02789 | DBMET02789 | |
| 0.007 | 0.349 | 0.058 | Prostaglandin EP2 antagonist | 0.058 0.043 DBMET02789 | DBMET02789 | |
| 0.061 | 0.563 | 0.284 | Sodium/bile acid cotransporter inhibitor | 0.284 0.094 DBMET02789 | DBMET02789 | |
| 0.02 | 0.534 | 0.069 | Bcl-xL inhibitor | 0.069 0.021 DBMET02789 | DBMET02789 | |
| 0.006 | 0.662 | 0.049 | Plasminogen activator inhibitor antagonist | 0.049 0.034 DBMET02789 | DBMET02789 | |
| 0.005 | 0.749 | 0.185 | Mcl-1 antagonist | 0.185 0.064 DBMET02789 | DBMET02789 | |
| 0.005 | 0.827 | 0.173 | Protein-tyrosine phosphatase inhibitor | 0.173 0.061 DBMET02789 | DBMET02789 | |
| 0.004 | 0.837 | 0.082 | Peroxisome proliferator-activated receptor gamma agonist | 0.082 0.039 DBMET02789 | DBMET02789 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |